| 000 | 01881 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516113036.0 | ||
| 264 | 0 | _c20130523 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1756-9966 | ||
| 024 | 7 |
_a10.1186/1756-9966-31-80 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhu, Jian | |
| 245 | 0 | 0 |
_aDNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer. _h[electronic resource] |
| 260 |
_bJournal of experimental & clinical cancer research : CR _cSep 2012 |
||
| 300 |
_a80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBiomarkers, Pharmacological |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aDNA Methylation _xgenetics |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aEye Proteins _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Proteins _xgenetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aWnt Signaling Pathway |
| 700 | 1 | _aWang, Yuyan | |
| 700 | 1 | _aDuan, Jianchun | |
| 700 | 1 | _aBai, Hua | |
| 700 | 1 | _aWang, Zhijie | |
| 700 | 1 | _aWei, Lai | |
| 700 | 1 | _aZhao, Jun | |
| 700 | 1 | _aZhuo, Minglei | |
| 700 | 1 | _aWang, Shuhang | |
| 700 | 1 | _aYang, Lu | |
| 700 | 1 | _aAn, Tongtong | |
| 700 | 1 | _aWu, Meina | |
| 700 | 1 | _aWang, Jie | |
| 773 | 0 |
_tJournal of experimental & clinical cancer research : CR _gvol. 31 _gp. 80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1756-9966-31-80 _zAvailable from publisher's website |
| 999 |
_c22133064 _d22133064 |
||